Carregant...
Theranostics in immuno-oncology using nanobody derivatives
Targeted therapy and immunotherapy have become mainstream in cancer treatment. However, only patient subsets benefit from these expensive therapies, and often responses are short‐lived or coincide with side effects. A growing modality in precision oncology is the development of theranostics, as this...
Guardat en:
| Publicat a: | Theranostics |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831473/ https://ncbi.nlm.nih.gov/pubmed/31695800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.34941 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|